Introduction to Biologic and Biosimilar Product Development and Analysis

Nagel, Karen M.

Introduction to Biologic and Biosimilar Product Development and Analysis [electronic resource] / by Karen M. Nagel. - 1st ed. 2018. - XI, 109 p. 4 illus. in color. online resource. - AAPS Introductions in the Pharmaceutical Sciences, 2522-834X . - AAPS Introductions in the Pharmaceutical Sciences, .

Acceso multiusuario

Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.

The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.

9783319984285


Pharmaceutical technology.
Pharmacy.
Pharmaceutical Sciences/Technology.
Pharmacy.

RS380 RS190-210

615.19

Con tecnología Koha